Show All
Where is Tyra Biosciences headquartered?
2656 State Street, Carlsbad CA 92008
Where is Tyra Biosciences incorporated?
Tyra Biosciences is incorporated in Delaware.
When was Tyra Biosciences founded?
Tyra Biosciences was founded in 2018.
Which stock exchange are Tyra Biosciences shares traded on and what is the company’s ticker?
Tyra Biosciences’ shares are traded on the Nasdaq Global Market under the symbol “TYRA”.
When did Tyra Biosciences go public?
Tyra went public on September 14, 2021.
When does Tyra Biosciences’ fiscal year end?
Tyra Biosciences’ fiscal year ends on December 31.
Who is Tyra Biosciences’ independent registered public accounting firm?

Ernst & Young LLP

Who is Tyra Biosciences’ legal counsel?
Latham & Watkins LLP
12670 High Bluff Drive
San Diego, California 92130
How can I purchase Tyra Biosciences shares?
Shares of Tyra Biosciences’ stock can be purchased by contacting a securities broker of your choice.
Can I purchase shares directly from Tyra Biosciences?
No. Tyra does not have a direct stock purchase plan. You may purchase shares of Tyra through a broker of your choice.
Who is Tyra Biosciences’ transfer agent?
Computershare Trust Company, N.A
Whom do I contact with questions about my stock (transfer stock, change the address on my shareholder account, or replace a lost stock certificate)?
For questions about your stock, please contact our transfer agent, Computershare Trust Company, N.A., 150 Royall Street, Suite 101, Canton, MA 02021 or P.O. Box 43006, Providence, RI 02940-3006.
How can I view documents Tyra Biosciences has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Quarterly & Annual reports and other investor materials are available in the “Investors” section of Tyra Biosciences’ corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at
How can I sign up to receive Tyra Biosciences press releases and other company information?

Please click here to be directed to the email alerts page.

Whom should I contact if I have additional questions?
For media and investor inquiries, please send an email to